| Craig Tuchon, LCSW | |
|
9 Pine Hollow Rd, West Warwick, RI 02893-5437 | |
| (401) 626-5796 | |
| Not Available |
| Full Name | Craig Tuchon |
|---|---|
| Gender | Male |
| Speciality | Social Worker - Clinical |
| Location | 9 Pine Hollow Rd, West Warwick, Rhode Island |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1619635042 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | CSW02523 (Rhode Island) | Primary |
| Entity Name | Supportive Care I Of Rhode Island Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1912666454 PECOS PAC ID: 1951793546 Enrollment ID: O20220111000885 |
News Archive
Aerospace giant Boeing tested two kinds of ionization technologies — like those widely adopted in schools hoping to combat covid — to determine how well each killed germs on surfaces and decided that neither was effective enough to install on its commercial planes.
QLT Inc., a company dedicated to the development and commercialization of innovative therapies for the eye, announced today that the company has been added to the Russell Global Index. The 2010 reconstitution of the Russell Indexes, a comprehensive set of U.S. and global equity indexes created by Russell Investments, took place after the market close on June 25, 2010.
LifeVantage Corporation, the maker of Protandim®, a clinically proven, science-based therapy for oxidative stress, announced today that a new peer-reviewed study involving Protandim® was published in the scientific journal PLoS ONE. The study, conducted by researchers at Louisiana State University, examined the biochemical mechanisms that underlie the ability of Protandim® to suppress tumors in mice. That ability was previously demonstrated by the authors in a study involving a mouse two-stage model of chemically-induced skin cancer.
A new study suggests that many adults have large amounts of brown fat, the "good" fat that burns calories to keep us warm, and that it may be possible to make even more of this tissue.
Melanoma patients who receive treatment with targeted therapies experience an initial response that feels like a cure, but that early excitement is quickly dampened when patients relapse as their cancers find alternative pathways in our cells to grow and spread. With melanoma so good at escaping targeted treatments, there's a dire need to halt these cancers in their tracks to prolong good responses and promote longer, healthier lives.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Craig Tuchon, LCSW 9 Pine Hollow Rd, West Warwick, RI 02893-5437 Ph: (401) 626-5796 | Craig Tuchon, LCSW 9 Pine Hollow Rd, West Warwick, RI 02893-5437 Ph: (401) 626-5796 |
News Archive
Aerospace giant Boeing tested two kinds of ionization technologies — like those widely adopted in schools hoping to combat covid — to determine how well each killed germs on surfaces and decided that neither was effective enough to install on its commercial planes.
QLT Inc., a company dedicated to the development and commercialization of innovative therapies for the eye, announced today that the company has been added to the Russell Global Index. The 2010 reconstitution of the Russell Indexes, a comprehensive set of U.S. and global equity indexes created by Russell Investments, took place after the market close on June 25, 2010.
LifeVantage Corporation, the maker of Protandim®, a clinically proven, science-based therapy for oxidative stress, announced today that a new peer-reviewed study involving Protandim® was published in the scientific journal PLoS ONE. The study, conducted by researchers at Louisiana State University, examined the biochemical mechanisms that underlie the ability of Protandim® to suppress tumors in mice. That ability was previously demonstrated by the authors in a study involving a mouse two-stage model of chemically-induced skin cancer.
A new study suggests that many adults have large amounts of brown fat, the "good" fat that burns calories to keep us warm, and that it may be possible to make even more of this tissue.
Melanoma patients who receive treatment with targeted therapies experience an initial response that feels like a cure, but that early excitement is quickly dampened when patients relapse as their cancers find alternative pathways in our cells to grow and spread. With melanoma so good at escaping targeted treatments, there's a dire need to halt these cancers in their tracks to prolong good responses and promote longer, healthier lives.
› Verified 8 days ago
Miss Latonya C Pete, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 498 Providence St, West Warwick, RI 02893 Phone: 401-996-2141 | |
Jennifer Elizabeth Lewis, MSW, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 215 Washington St, West Warwick, RI 02893 Phone: 401-822-1360 | |
Sage Mueller, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 186 Providence St, West Warwick, RI 02893 Phone: 401-615-2800 | |
Jenna Danielle Monteiro, LICSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 186 Providence St, West Warwick, RI 02893 Phone: 401-615-2800 | |
Laura M Linback, MSW, LICSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 186 Providence St, West Warwick, RI 02893 Phone: 401-615-2800 | |
Colleen Mckenna, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 186 Providence St, West Warwick, RI 02893 Phone: 401-615-2800 | |
Susan Kelly, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 186 Providence St, West Warwick, RI 02893 Phone: 401-615-2800 |